Skip to main content
☩ AI Health Guide
Menu

Freed vs DeepScribe 2026: Head-to-Head AI Medical Scribe Comparison

Affiliate disclosure: This page contains affiliate links marked with ↗. If you sign up through one of these links, we earn a commission at no extra cost to you. Our rankings and reviews are editorially independent — affiliate relationships do not influence them. Health claims have not been verified by the FDA. Read our methodology →
A

AI Health Apps Editorial Team

Editorial Team, AI Health Guide

Updated

Reviewed against our methodology

About the editorial team  ·  Report an error

The Short Answer

Freed is the right choice for solo practitioners and small practices who need transparent pricing and a free trial. DeepScribe is the right choice for specialty practices, oncology departments, and mid-market hospitals who need specialty-tuned models, AI medical coding, and a published KLAS score (98.8/100 in a KLAS Emerging Company Spotlight). They serve different segments and rarely compete directly.

Pricing Comparison

PlanFreedDeepScribe
Entry tier$39/month (Starter, 40 notes)Not published
Standard tier$79/month (Core, unlimited notes)Not published
Premium tier$119/month billed monthly, or $104/month billed annually (Premier, ICD-10 + EHR push)Not published
Free trial7-day, no credit cardSales-led, no public trial
Public pricingYesNone found on deepscribe.ai

DeepScribe does not publish a price, so the cost gap cannot be stated; Freed lists $39–$119 per month.

Clinical Validation

DeepScribe holds a 98.8/100 score in a KLAS Emerging Company Spotlight, with 15 A+ grades across six categories; DeepScribe notes the report was written with limited data. Freed has no published clinical-outcome studies and no KLAS recognition. The one study we found in PubMed, a 2025 paper in South Dakota Medicine, compared Freed's notes with first-year medical students' notes in simulated clinical exams, which says little about real patient care. Freed's validation otherwise comes from its own reported 26,000+ clinicians and a $30M Series A led by Sequoia Capital, which is not the same kind of evidence.

For specialty groups where documentation quality directly affects coding revenue and clinical risk, DeepScribe has the stronger published validation. For solo and small practices where the alternative is no AI scribe at all, Freed's pragmatic adoption is the right answer.

Feature Comparison

FeatureFreedDeepScribe
Ambient SOAP note generationYesYes
Specialty-tuned modelsSpecialty-specific templates (20+ specialties, per Freed)Yes (oncology, cardiology, etc.)
AI medical coding (E/M, HCC, ICD-10)Premier tier and above (Coding Assistant: ICD-10, E/M, CPT)Yes, full coding suite
EHR integrationChrome extension pushBi-directional native integration
AI editing assistantEdit a note and ask Freed to learn your style ("Learn my format")Yes
Pre-charting from prior visitsYes (Premier: patient summaries before each visit)Yes
Real-time clinical insightsNoDeepScribe Assist

EHR Integration: The Key Differentiator

Freed pushes notes into browser-based EHRs (for example athenahealth, Practice Fusion, SimplePractice and Elation; Freed's EHR page lists 13 EHRs) via a Chrome extension, which Freed includes in Premier and Groups. DeepScribe describes its EHR integrations as "native, two-way" and lists Epic among them — meaning it can both write notes and read patient history for context-aware documentation. For practices with complex patients and rich EHR histories, that bidirectional integration is meaningfully valuable.

Who Wins for Each Scenario

ScenarioWinnerWhy
Solo family medicineFreed$79/month, published; DeepScribe publishes no price
Small group (2-5 providers)FreedCost-effective per-provider scaling
Specialty practice (oncology, cardiology)DeepScribeSpecialty-tuned models (we found no published study measuring the accuracy gain)
Mid-market hospitalDeepScribeKLAS validation, AI coding, deeper EHR integration
Coding-revenue sensitive practiceDeepScribeAI coding suite drives reimbursement accuracy
Brand-new AI scribe trialFreed7-day free trial with no credit card

Verdict

Freed and DeepScribe are not really competitors — they serve different segments. If you are a solo or small-group clinician, choose Freed. If you are a specialty practice or mid-market hospital where documentation quality and coding accuracy directly affect outcomes, choose DeepScribe. If you are a large enterprise health system on Epic, neither is the right answer — choose Abridge. Use this as a clarifying lens, not a head-to-head fight.

Frequently asked questions

Freed vs DeepScribe — which is cheaper?
Freed publishes its prices: Starter $39/month, Core $79/month, and Premier $119/month billed monthly or $104/month billed annually. DeepScribe does not publish pricing, so we cannot compare the two on price.
Which produces better notes?
Both produce good notes for the audience they target. DeepScribe has historically been stronger on specialty-specific note quality (orthopaedics, cardiology) where structured coding accuracy matters. Freed produces clean primary-care and general-medicine notes; specialty depth is improving but uneven. For a primary-care solo practice, the note-quality difference rarely justifies the price premium.
Is Freed suitable for a multi-specialty group?
Freed Premier supports team accounts and specialty templates. Smaller multi-specialty groups (2–10 providers) report good outcomes. Larger groups with deep specialty needs (especially cardiology, oncology, ophthalmology) typically find DeepScribe or Suki a better fit due to template depth.
Which has better EHR integration?
DeepScribe has more mature EHR integration breadth across mid-market practice management systems. Freed supports several browser-based EHRs through a Chrome extension but is less mature on enterprise-EHR workflows. Neither matches Abridge or Nuance DAX for native Epic Hyperspace embedding.
What about KLAS rankings?
Abridge currently leads ambient AI scribe KLAS rankings (#1 Best in KLAS for Ambient AI in 2025 and 2026). Freed is too new and too solo-focused to have full KLAS coverage; expect more in 2027.
For Clinicians: Freed Try Freed ↗